The Nasdaq Biotechnology Index rose by 1.3%, temporarily outperforming the three major U.S. stock indices
Component stocks Precigen rose 14.48%, Prime Medicine rose 12.28%, Esperion rose 11.00%, Rocket Pharma rose 10.81%, Editas Medicine rose 10.44%. Grail fell 2.11%, Y mAbs Therapeutics fell 2.22%, Fortrea Holdings fell 2.69%, Silence Therapeutics fell 2.79%, Biomea Fusion fell 2.91%, Mesoblast fell 9.16%